Document:

<PAGE>
                                                                   Exhibit 10.19

                                    AGREEMENT

            THIS AGREEMENT is entered into and effective this 30th day of
September, 2002 by and between Vital Living, Inc., a Nevada corporation ("VL")
and Medical Resource, LLC, National Provider Network, both of which are
subsidiaries of A.C.E. Health, LLC., a managed health care company (hereinafter
"PPO").

                                    RECITALS

            1.    VL is in the business of among other things developing and
                  distributing a proprietary line of nutritional products,
                  marketed under the name Essentum(TM) and Essentum N.P. for use
                  by heart and vascular patients. ("Product(s)". This
                  "Agreement" is for the sole purpose of Essentum(TM) and
                  Essentum N.P. and any other products that may be mutually
                  agreed to by the parties.

            2.    Medical Resource LLC., through it's own national PPO and its
                  PPO's affiliates operate a preferred provider network,
                  National Provider Network (NPN).

            3.    PPO, directly or through its networks, is affiliated with in
                  excess of 300,000 physicians.

            4.    PPO, directly or through its networks, is affiliated with in
                  excess of 30,000 ancillary facilities and hospitals.

            The Company also wishes to assist in distributing the Products to
its PPO, PPO affiliates, medical facilities and other distribution channels,
both parties agree to develop a marketing agreement, which will identify
specific target groups and providers. The parties therefore agree to the
following terms and conditions:

                              TERMS AND CONDITIONS

      1.    Product Ordering and Delivery Protocol: PPO agrees to follow the
            protocol listed on Exhibit 1 in respect of the ordering and delivery
            of the Product.

      2.    Product Manufacture: VL will be solely responsible for manufacturing
            the Product in accordance with the specified Product formulations.
            VL, or VL's subcontractor, will manufacture all "Products" in
            accordance with industry standards for similar products. VL will
            ensure that the Product meets all government standards or other
            regulations for such products, if any. VL will

Page 1 of 6
<PAGE>
            maintain a reasonable inventory of the Product for marketing and
            promotional purposes.

      3.    Payment Terms: Payment terms are set forth on Exhibit 2.

      4.    Term: The Agreement will continue for three years from the effective
            date of this Agreement and will automatically renew for additional
            one-year terms unless either party gives notice of its intent not to
            renew the agreement not less than sixty (60) days prior to the end
            of the then current term. Either party may terminate the Agreement
            for cause or breach of material term or condition upon thirty (30)
            days written notice. If the agreement is terminated after
            distribution of the Product has begun, "VL" may have 180 days to
            distribute any Product still in inventory if it bears the PPO logo
            or endorsement.

      5.    Liability: VL will maintain product liability insurance in such
            amounts agreed to by the parties. PPO will be named as an additional
            insured under any policy related to manufacture and sale of the
            Product. VL will further indemnify all PPO and PPO Affiliates
            officers, directors, employees, and all subsidiaries of A.C.E.
            Health, LLC, from any liability relating to third-party use of the
            Product.

      6.    Confidentiality: In connection with this Agreement, the parties will
            develop, acquire, or be granted access to trade secrets and other
            information that is confidential and proprietary to the parties or
            to third parties. Such information includes but is not limited to
            patient lists and information, costs of manufacturing, product
            formulations, technical data, methods, processes, expertise,
            business and marketing strategies, operations, research and
            development, business opportunities, and financial data. The parties
            will not at any time during or after termination of this Agreement,
            directly or indirectly, divulge, use or permit the use of any
            confidential or proprietary information of the other, except as
            required in the course of this Agreement. Upon termination of this
            Agreement, the parties will immediately turn over to the other all
            confidential information materials belong to such part, including
            all copies thereof or notes relating thereto, in such party's
            possession or otherwise subject to its control. Notwithstanding the
            above, the following materials will not be deemed confidential:

                  (i) Information which was in the public domain at the time of
disclosure (provided, however, that collection or compilation of publicly
available information will be considered proprietary if the disclosing party's
collection or organization of the material would be difficult or time-consuming
to replicate);

                  (ii) Information which was published or otherwise became part
of the public domain after disclosure to the receiving party through no fault of
the receiving party (but only after, and only to the extent that, it Is
published or otherwise becomes a part of the public domain); and

Page 2 of 6
<PAGE>
                  (iii) Information, which was, received from a third party who
did not acquire it, directly or indirectly, from the disclosing party under an
obligation of confidence except where required by law. The receiving party will
have the burden of establishing the existence of these conditions by objective
or verifiable evidence.

For the avoidance of doubt, VL will own all trademarks and other intellectual
property related to the Product, as well as all packaging and marketing except
for any PPO logo or trademark incorporated in the Product packaging.

      7.    Notice: Any notice or other communications required or that may be
            given pursuant to this Agreement will be in writing and will be
            delivered personally, facsimile, electronic mail with confirmation
            by recognized overnight carrier to the address of the party as set
            forth below, or to any other address requested by the respective
            parties after giving written notice to the other party.

      8.    Governing Law: This Agreement will be governed by and construed in
            accord with the laws of the State of Arizona. All disputes will be
            resolved by binding arbitration under the Commercial Arbitration
            Rules of the American Arbitration Association in Phoenix, Arizona,
            except that either party may apply to a court of competent
            jurisdiction solely for interlocutory injunctive relief to maintain
            the status quo pending the results of the arbitration. The
            prevailing party in any dispute will be entitled to recover its
            reasonable attorneys' fees and related costs and expenses incurred
            in connection therewith.

      9.    Severability: If any court of competent jurisdiction rules any
            provision of this Agreement invalid, illegal, or unenforceable, the
            validity, legality, and enforce ability of the remaining provisions
            will not be affected or impaired in any way.

      10.   Non-Solicitation: VL agrees that it will not directly or indirectly
            sell or otherwise solicit any members or participants in the PPO
            other than through the terms and provisions of this Agreement.

      11.   Entire Agreement: This Agreement constitutes the entire, integrated
            agreement among the parties regarding the subject matter hereof and
            supersedes any and all prior and agreements, representations, and
            understandings of the parties.

      12.   Assignment: Neither party will assign this Agreement or any of its
            rights or obligations without the prior consent of the other party.
            Provided, however, that either party may assign this Agreement and
            its rights and obligations hereunder, with prior notice to the other
            party to any person or entity that purchases all or substantially
            all of its assets, or that merges with or into such assigning party,
            or that is under common ownership or control of the assigning party,
            and that agrees in writing to be bound by the terms hereof.

Page 3 of 6
<PAGE>
VITAL LIVING, INC.,                            ________________________________
A Nevada corporation                           a_______________________________

By: /S/ Bradley D. Edson                     By: ______________________________
Printed Name: Bradley D. Edson               Printed Name: ____________________
Its: C.E.O.                                  Its: _____________________________

Address:                                    Address:
5080 N. 40th Street, Suite 105              ___________________________________
Tempe, Arizona 85018-2147
                                            ___________________________________

Page 4 of 6
<PAGE>
                                    Exhibit 1

PPO will fax or electronically transmit a weekly list of all orders, with
addresses. VL will directly ship such orders to each patients address, by UPS or
other comparable service.

Page 5 of 6
<PAGE>
                                    Exhibit 2

PPO shall be responsible for paying the cost of the product at the then current
Wholesale Price, and related shipping charges. The Wholesale Price shall be
$24.00 per package, which price may change from time to time by VL upon 30 days
written notice to PPO. Notwithstanding the foregoing, the Wholesale Price will
not be changed by VL for the first 180 days from the inception of the first
order.

Payment shall be due from PPO on placement of orders to VL.

Page 6 of 6<PAGE>
                                                                   Exhibit 10.20

                              CONSULTING AGREEMENT

      THIS CONSULTING AGREEMENT dated as of October 8, 2002 by and between
Martin Wallace (hereinafter referred to as "Consultant"), having an office at
351 E. 84th Street, Suite 29c , New York, NY 10028 and Vital Living, Inc., 5080
N. 40th Street, Suite 105 Phoenix, Arizona 85018 (the "Company").

      The Company is engaged, inter alia, in the formulation and marketing of
condition specific supplements formulated by physicians for distribution through
physicians, as an integral part of patient treatment protocols. The Consultant
is engaged in the marketing of nutraceuticals to physician preferred provider
organizations, health plans, medical groups, and other medical service entities
(collectively, "Medical Service Providers" or "MSP").

      The Company wishes to retain the services of the Consultant to market the
Company's nutraceutical product for cardiovascular patients marketed under the
name Essentum (TM) (the "Product") to various MSPs for the purposes of entering
into Conforming Contracts (as defined below) with the Company pursuant to which
such MSP will promote, and recommend the Company's products to its members (the
foregoing being described herein as "Services"), and Consultant has agreed to
provide the Services to the Company, pursuant to the terms hereof;

      NOW, THEREFORE, in consideration of the mutual premises and covenants
herein contained, the parties hereto agree as follows:

1. ENGAGEMENT.

      (a) Company hereby engages Consultant to provide the non-exclusive
Services pursuant to the terms and conditions hereof. Consultant shall be
obligated to follow only the direction and supervision of Company's senior
executives (presently Brad Edson, Ken Lind and Stuart Benson).

      (b) Consultant shall provide, on a monthly basis, written reports as to
the Services rendered hereunder, and shall respond verbally at the request of
the Company to any inquiries made by the Company in that regard.

2. COMPENSATION.

      (a) In exchange for the full, prompt and satisfactory performance of the
Services, but expressly coordinated on the execution of a Conforming Contract
(as defined below), Company shall pay the Consultant a monthly retainer fee of
$7,500.00 (the "Monthly Retainer"), inclusive of any expenses incurred by
Consultant. The Monthly Retainer shall be paid on the date the first Conforming
Contract (as such term is defined below) is entered into by the Company (such
date being the "Initial Payment Date") and shall continue until the Termination
Date.
<PAGE>
      (b) In addition to the Monthly Retainer, the Company shall pay a
commission to Consultant equal to the "Excess Price" for each unit of the
Product sold by Consultant. "Excess Price" shall mean the amount received by the
Company, net of returns (which may be estimated by the Company), in excess of a
$22.00 per Unit price, plus shipping and handling costs (not to exceed $6.00 per
Unit), (the then effective Unit cost, plus such other costs, being referred to
as the "Wholesale Price"). The Company may adjust the Wholesale Price, at any
time, or from time to time, upon 30 days notice to Consultant; provided however,
the Wholesale Price cannot be adjusted by the Company for the first 180 days
following the date of the first Conforming Contract.

      (c) When the Board of Directors next meets to award nonqualified stock
options, Consultant's name will be submitted by management of the Company to
receive nonqualified stock options (the "Options") to acquire up to 500,000
shares of the Company's common stock at an exercise price equal to $2.00. The
terms of any option grant are subject to board approval and a formal written
option agreement; it being acknowledged and agreed that such Options shall vest
at a rate equal to 2 times the number of Units of paid in full orders for the
Product from "Conforming Contracts" (as such term is defined below) during the
first twelve months of this Agreement. For purposes of this Agreement, a
Conforming Contract is contract with a MSP which (i) agrees to actively endorse
, and promote the Products and who contractually agrees that the Products will
be the exclusive products endorsed and promoted by them relative to the
particular disease for which it is intended, (ii) agrees to advertise the
Product and logo in selected printed materials, and which will display the
Company's Product in its offices, and (iii) has a term of no less than one year.
All agreements will be negotiated and executed by the Company, and Consultant
shall have no authority to execute any such agreements on behalf of the Company.
For the avoidance of doubt, Consultant shall not act as an agent for Company and
shall not hold itself out to third parties as if it had apparent or actual
authority to, among other things, contractually bind the Company, incur
liabilities on Company's behalf, or enter into any other type of written or oral
commitment by or on behalf of the Company

      (d) Notwithstanding anything in this agreement to the contrary, Consultant
may not solicit any MSP without the prior written approval of the Company and
Consultant shall be entitled to the fees and options described in this Section 2
with respect to all sales of the Product to any MSP introduced by Consultant for
the term of this Agreement and one year after this Agreement is terminated for
any reason other than upon material breach by the Consultant.

      3. TERM AND TERMINATION. This agreement shall commence on the date first
above written and may be terminated, whether the Initial Payment Date has
occurred, in the following manner in the specified circumstances:

      (a) By the Company at any time after three months from the date hereof if
no Conforming Contracts have been entered into.

      (b) By the Company, upon any material breach by the Consultant of the
provisions of this Agreement; provided, however, the Consultant shall receive
written notice of the foregoing and shall have 5 days in which to cure such
breach or conduct, if curable.

      (c) By mutual agreement of the parties.

      (d) The parties agree that any termination of this Agreement will not
release nor discharge the parties from their obligations as specified in
Sections 2, 4, 5, 6, 7, and 8 of this Agreement.

      Unless otherwise extended in writing by the Company, and unless previously
terminated pursuant to the provisions set forth above, this agreement shall
automatically terminate one year after the Initial Payment Date (the
"Termination Date").

4. NONSOLICITATION OF COMPETITOR. During the period of this Agreement and for an
equal period of time following the expiration of this Agreement for any reason
whatsoever), Consultant shall not, directly or indirectly, alone or as a
partner, officer, director, employee, consultant, independent contractor, agent
or stockholder of any entity, consult with any direct competitor of Company as
it relates to the Product.

5. NONSOLICITATION/NON-HIRE OF EMPLOYEES. During the period of this Agreement
and for a period of twelve (12) months after its termination (for any reason
whatsoever), Consultant shall not, directly or indirectly: (a) employ; (b)
knowingly permit any company or business organization which is directly or
indirectly controlled by Consultant to employ; (c) recruit or attempt to
recruit, solicit or attempt to solicit, attempt to hire, interfere with or
endeavor to entice away; or (d) assist any entity, company or business
organization to recruit or attempt to recruit, solicit or attempt to solicit,
attempt to hire, interfere with or endeavor to entice away any person who is at
the time employed by Company.

6. NONDISCLOSURE OBLIGATION.

      (a) The Consultant acknowledges that the Company and its affiliates have,
prior to the date hereof, disclosed and may, following the date hereof, disclose
to the Consultant certain highly confidential information, trade secrets and
other proprietary information relating to the business of the Company and its
affiliates. During the Term and for a period of one year thereafter, the
Consultant covenants and agrees that it will not use or disclose to any other
person, except Consultant's employees and its affiliates, without the Company's
prior written approval, any confidential business information, trade secrets or
other proprietary information of the Company obtained or learned by the
Consultant during or prior to the Term. The Consultant shall take reasonable
steps necessary to ensure that its employees, agents, affiliates and contractors
do not discuss, divulge or utilize any confidential information communicated to
or acquired by them. All copies of all documents prepared by or made available
to the Consultant during the Term shall be delivered to the Company upon
termination of this Consulting Agreement or at the Company's request, at any
other time

      (b) Confidential information includes, but is not limited to, research and
development activities, product designs, prototypes and technical
specifications, show how and know how,
<PAGE>
marketing plans and strategies, pricing and costing policies, customer and
suppliers lists and accounts, nonpublic financial information, systems,
processes, software programs, works of authorship, inventions, projects, plans
and proposals. Confidential information shall not include any information which
is publicly known, was known to Consultant prior to disclosure by the Company or
was independently developed by Consultant. Consultant shall keep secret and
shall not use or attempt to use any confidential information except as may be
required in the ordinary course of performing Consultant's Services as a
consultant of Company , nor shall Consultant use any confidential information in
any manner which may injure or cause loss or may be calculated to injure or
cause loss to Company, whether directly or indirectly.

7. COMPANY DOCUMENTATION. Consultant further agrees that during the term of this
Agreement, Consultant shall not make, use or permit to be used any Company
documentation otherwise than for the benefit of Company. Company documentation
includes, but is not limited to, notes, memoranda, reports, lists, records,
drawings, sketches, specifications, software programs, data documentation or
other materials of any nature and in any form, whether written, printed or in
digital format or otherwise relating to any matter within the scope of the
business of Company or concerning any of its dealings or affairs. Company
documentation shall not include any of the foregoing which is publicly known,
was known to Consultant prior to disclosure by the Company or was independently
developed by Consultant. Consultant further agrees that he shall not, for one
year after the termination of this Agreement (for any reason whatsoever), use or
permit others to use any such Company documentation, it being agreed that all
Company documentation shall be and remain the sole and exclusive property of
Company. Immediately upon the termination of this Agreement, Consultant shall
deliver all Company documentation in Consultant's possession, and all copies
thereof, to Company at its main office.

8. INDEPENDENT CONTRACTOR. It is expressly understood and agreed that during the
term of this Agreement, the Consultant's relationship to Company will be that of
an independent contractor and that neither this Agreement nor the services to be
rendered hereunder shall for any purpose whatsoever or in any way or manner
create, expressly or by implication, any employer-employee relationship,
partnership, joint venture or other relationship with Company other than that of
independent parties contracting with each other solely for the purpose of
carrying out the provisions of the Agreement. Accordingly, Consultant
acknowledges and agrees that he shall not be entitled to any benefits provided
by Company to its employees (including, without limitation, such items as health
and disability benefits). In addition, the Consultant shall have sole and
exclusive responsibility for the payment of all federal, state and local income
taxes, for all employment and disability insurance and for Social Security and
other similar taxes with respect to any compensation provided by Company
hereunder. The Consultant further agrees that if Company pays or becomes liable
for such taxes or related civil penalties or interest as a result of the
Consultant's failure to pay taxes or report same, or due to Company's failure to
withhold taxes, the Consultant shall indemnify and hold Company harmless for any
such liability. The Consultant shall assume and accept all responsibilities that
are imposed on independent contractors by any statute, regulation, rule of law
or otherwise. The Consultant is not authorized to bind Company, or to incur any
obligation or liability on behalf of Company, except as expressly authorized by
Company in writing. Further, the Consultant understands and agrees that the work
to be performed is not covered under the unemployment compensation laws and that
the
<PAGE>
work to be performed is not intended to be covered by applicable worker's
compensation laws.

9. WARRANTIES AND REPRESENTATIONS

      (a) Consultant warrants and represents that:

            (i) He is authorized, empowered and able to enter into and fully
perform the obligations hereunder; and

            (ii) The services to be rendered hereunder shall not be in violation
of any law, regulation or third party agreement.

      (b) The Company warrants and represents that the Company is authorized,
empowered and able to enter into and fully perform the Company's obligations
hereunder.

10. MISCELLANEOUS.

      (a) This Consulting Agreement contains, and is intended as, a complete
statement of all of the terms of the arrangement between the parties with
respect to its subject matter and supersedes all previous negotiations,
promises, agreements and understandings with respect to those matters.

      (b) The Consultant represents that his performance of all the terms of
this Consulting Agreement does not and will not breach any non-competition
agreement and/or agreement to keep in confidence proprietary information,
knowledge or data acquired by the Consultant in confidence from other entities
besides Company, and the Consultant will not disclose to Company or induce
Company to use any confidential or proprietary information or material belonging
to any previous employer, client or others.

      (c) No provision of this Consulting Agreement shall be waived, amended,
modified, superseded, canceled, terminated, renewed or extended except in a
written instrument signed by the party against whom any of the foregoing actions
is asserted. Any waiver shall be limited to the particular instance and for the
particular purpose when and for which it is given.

      (d) Consultant hereby agrees that each provision herein shall be treated
as a separate and independent clause, and the unenforceability of any one clause
shall in no way impair the enforceability of any of the other clauses of the
Agreement. Moreover, if one or more of the provisions contained in this
Agreement shall for any reason be held to be excessively broad as to scope,
activity, subject or otherwise so as to be unenforceable at law, such provision
or provisions shall be construed by the appropriate judicial body by limiting or
reducing it or them, so as to be enforceable to the maximum extent compatible
with the applicable law as it shall then appear. Consultant hereby further
agrees that the language of all parts of this Agreement shall in all cases be
construed as a whole according to its fair meaning and not strictly for or
against either of the parties.

      (e) This Consulting Agreement, the Services to be performed and all rights
hereunder
<PAGE>
are personal to the Consultant and may not be transferred or assigned by the
Consultant at any time. Company may assign this Consulting Agreement to its
successors and assigns and all rights and obligations under this Agreement will
inure to the benefit of and be binding upon such successors and assigns.

      (f) This Consulting Agreement shall be construed and enforced in
accordance with the internal laws of the State of New York without reference to
its conflicts of laws provisions.

      (g) Consultant agrees that any breach of this Agreement by Consultant will
cause irreparable damage to Company and that in the event of such breach Company
shall have, in addition to any and all remedies of law, the right to an
injunction, specific performance or other equitable relief to prevent the
violation of Consultant's obligations hereunder.

      (h) Any notice required or permitted to be given hereunder shall be
effective when received at the addresses indicated above, and shall be deemed
received when delivered to the parties by certified mail, return receipt
requested. Any notice, demand or other communications may also be transmitted by
telecopier or facsimile and when so transmitted shall be deemed received on the
date of its transmission.

      (j) Headings in this Consulting Agreement are for convenience only and
shall not be used to interpret or construe its provisions.

      IN WITNESS WHEREOF, the parties have executed this agreement as of the
date first above written.

Vital Living, Inc.

   By:___________________

   Its.__________________

____________________
Martin Wallace

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}]]